← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

# Name Holding Trade Value Theme
Stocks
% of
Portfolio
Status
351
Palisade Capital Management
Palisade Capital Management
New Jersey
$26.4M -$384K 1 0.72% Reduced
352
MAP
Managed Asset Portfolios
Michigan
$26.1M -$1.43M 1 3.86% Reduced
353
Simplify Asset Management
Simplify Asset Management
Nevada
$26M +$4.26M 5 1.74% Increased
354
MP
Mangrove Partners
Connecticut
$26M $0 1 1.99% Maintained
355
Vestmark Advisory Solutions
Vestmark Advisory Solutions
Massachusetts
$25.8M -$3.78M 7 1.08% Reduced
356
CI Investments Inc
CI Investments Inc
Ontario, Canada
$25.7M -$1.4M 9 0.1% Reduced
357
ING Group
ING Group
Netherlands
$25.6M -$45.1K 2 0.15% Reduced
358
KCM
Kynam Capital Management
New Jersey
$25.6M +$1.85M 2 1.98% Increased
359
EAM
EFG Asset Management
Oregon
$25.6M +$1.86M 7 4.43% Increased
360
PP
PDT Partners
New York
$25.3M +$332K 12 2.4% Increased
361
Wasatch Advisors
Wasatch Advisors
Utah
$25.2M +$2.83M 3 0.13% Increased
362
SCM
Superstring Capital Management
New York
$25.1M +$1.27M 7 31.7% Increased
363
TC
TwinBeech Capital
New York
$24.8M +$22.2M 7 0.49% Increased
364
DG
Daventry Group
New York
$24.7M +$914K 1 11.04% Increased
365
AssetMark Inc
AssetMark Inc
California
$24.7M -$65.4K 7 0.08% Reduced
366
MIM
Martin Investment Management
Florida
$24.4M -$789K 1 6.25% Reduced
367
Brandes Investment Partners
Brandes Investment Partners
California
$23.9M +$1.03M 1 0.29% Increased
368
DC
Decheng Capital
California
$23.8M +$627K 4 7.3% Increased
369
Kestra Advisory Services
Kestra Advisory Services
Texas
$23.8M +$15.5M 5 0.13% Increased
370
OM
Opaleye Management
Massachusetts
$23.7M +$4.34M 4 5.41% Increased
371
NM
Newtyn Management
New York
$23.6M +$16.3M 3 4.42% Increased
372
Optiver Holding
Optiver Holding
Netherlands
$23.6M +$1.09M 8 0.01% Increased
373
AVLSA
Atlas Venture Life Science Advisors
Massachusetts
$23.3M $0 1 2.46% Maintained
374
Royce & Associates
Royce & Associates
New York
$23.3M +$3.21M 4 0.22% Increased
375
LCM
Lakewood Capital Management
New York
$23.1M -$227K 1 1.89% Reduced